Current Wound Care
The treatment of chronic and non healing wounds, especially in diabetic patients, remains one of the most persistent and costly challenges in healthcare. Diabetic foot ulcers (DFUs) and related chronic wounds not only diminish patients' quality of life but also significantly increase the risk of infection, hospitalization, and amputation. Despite decades of research, traditional wound care approaches continue to fall short when faced with the complexity of diabetic wound pathophysiology.

Advanced Smart Wound Care Dressings
Emerging research into hydrogel-based wound dressings has opened new avenues for therapeutic intervention. These hydrogels offer excellent moisture retention, biocompatibility, and sustained- release properties. However, although clinically validated, conventional hydrogels like hyaluronic acid (HA) dressings are fundamentally passive. They do not adapt to the ever- changing biochemical and biophysical environment of a chronic diabetic wound.

McCord Smart Wound Care Products
This is where BioClense®, BioRelese®, and AgFresh® stand apart. These products represent a new generation of "smart hydrogels" engineered to respond to the wound microenvironment actively. By dynamically adjusting their behavior based on cues like pH, ionic concentration, and pathogen presence, they support each stage of wound healing more effectively than legacy technologies. These adaptive properties not only align with the clinical demands of treating diabetic wounds but also meet the regulatory and economic. imperatives of modern healthcare systems.